All Phage Therapy articles
-
NewsScientists probe antiviral molecules in bacteria that target bacteriophages
Researchers have examined the antiviral molecule daunorubicin, produced by Streptomycetes, and decoded its mode of operation against viruses. They now describe this mechanism, which primarily targets a specific group of viruses – namely bacteriophages.
-
NewsThe future of phage therapy will be decided by more than science alone
As antimicrobial resistance accelerates worldwide, leading experts gather in Valencia to address the scientific, regulatory, manufacturing and clinical challenges that will determine whether phage therapy becomes a routine healthcare solution.
-
NewsGladstone launches Center for PhAIge Therapy to harness AI in the fight against drug-resistant infections
Gladstone Institutes has received funding to establish the Center for PhAIge Therapy, a research center that will develop new phage-based treatments for antibiotic-resistant bacterial infections. The five-year grant makes Gladstone one of three institutions across the country selected to lead this coordinated effort.
-
NewsProtection for newborns: New treatment aims to prevent meningitis without antibiotics
One of the leading pathogens responsible for meningitis cases in newborn babies is the K1 form of the E. coli bacterium. Now, researchers have developed a triple-pronged approach that seeks to prevent transmission to newborns.
-
NewsEstablishing a regulatory framework for phage therapy in China
A new study summarizes the current regulatory frameworks for phage therapy in Western countries and China, and proposes a pathway for establishing a regulatory framework that enables safe and effective clinical application of phage therapy in China.
-
NewsResearchers advance phage therapy in fight against antimicrobial resistance
Scientists have uncovered how Mycobacterium abscessus can evade bacteriophage therapy, and demonstrated a combination strategy to overcome this resistance, offering a pathway towards more effective and durable treatments.
-
NewsResearchers uncover three families of ‘sponge’ proteins deployed by phages
Using an innovative research approach that combines artificial intelligence with experimental biology, researchers have uncovered new families of sponge proteins in phage genomes that disrupt immune communication in bacteria.
-
NewsPhage therapy at a turning point: Valencia 2026 to define the next era of antibacterial medicine
The Targeting Phage Therapy 2026 Congress will bring together leading scientists, clinicians, microbiologists, engineers, biotech leaders, regulators, hospital teams, start-ups, and innovators to ask: How can phage therapy move from promising science to accessible, validated, and deployable medicine?
-
NewsResearchers deploy phage therapy in new frontier against antimicrobial resistant infectious diseases
A revelatory treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.
-
NewsCall for evidence: Why has the promise of personalised medicine failed to materialise on the ground?
A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.
-
NewsResearchers find a gentler way to treat aggressive gum disease
Researchers have discovered that the primary bacterium driving gum disease carries an internal “genetic brake” that controls its own aggression. By locking this brake in place, future treatments could silence the pathogen while leaving beneficial bacteria untouched.
-
NewsSilent enemies, smart weapons - switching off phage contamination using nanoparticles
Bacteriophages represent a serious threat to laboratories and industries that rely on bacterial cultures for production. Researchers have demonstrated an innovative solution that enables targeting the surface of bacteriophage through electrostatic interactions.
-
NewsNew study reveals a minimalist bacterial defense that disrupts viral assembly
Researchers describe how a single protein named Rip1 recognizes bacteriophages, the viruses that infect bacteria, and cause infected bacteria to die prematurely, thereby ending the chain of transmission.
-
NewsHow bacteria learned to target numerous cell types, revealed
A new study shows how bacteria adapted a virus-derived injection system to recognize and attach to many different types of cells. By identifying thousands of rapidly evolving receptor-binding proteins, the researchers explain how these systems can be retargeted in nature by swapping the part that binds to cells.
-
NewsPIXL Max: Automated colony picker breaks records for speed and accuracy
With the latest innovation from the team at Singer Instruments, a new standard for speed and repeatability in microbial colony pickers has been achieved through the integration of cutting edge AI technologies.
-
NewsNexaBiome accelerates development of novel diabetic foot treatment with Scottish Enterprise funding
UK biotechnology company NexaBiome Life Sciences Ltd has received continued funding from Scotland’s national economic development agency, Scottish Enterprise, to accelerate its breakthrough bacteriophage technology for the treatment of diabetic foot infections (DFIs).
-
NewsGolden Gate method enables rapid, fully-synthetic engineering of therapeutically relevant bacteriophages
Researchers have described the first fully synthetic bacteriophage engineering system for Pseudomonas aeruginosa. In this method, researchers engineer bacteriophages synthetically using sequence data rather than bacteriophage isolates.
-
FeaturesUnlocking the secrets of phages: DNA modification discoveries offer new weapons against antimicrobial resistance
Bacteria and their viral predator bacteriophages (phages) have coevolved for billions of years and are engaged in an endless arms race against each other. DNA modifications are among the most widespread defenses to block bacterial RM and CRISPR-Cas systems.
-
NewsAboard the International Space Station, viruses and bacteria show atypical interplay
In a new study, terrestrial bacteria-infecting viruses were still able to infect their E. coli hosts in near-weightless “microgravity” conditions aboard the International Space Station, but the dynamics of virus-bacteria interactions differed from those observed on Earth.
-
NewsScientists reveal how excess hydrogen triggers metabolic shifts and viral defense in syngas microbiomes
Syngas biomethanation—converting CO/CO₂/H₂ into renewable methane—relies on coordinated microbial interactions. A study reveals that excess hydrogen disrupts this balance, reducing methanogenesis efficiency and triggering major shifts in microbial metabolism and viral dynamics.